AzTrials
AzTrials

Intubation ComplicationDA-VITIONNCT05884645

The DAnish VIdeo IntubaTION (DA-VITION) Study

An observational study of Intubation Complication and Intubation; Difficult or Failed, run by Lise Aunsholt at 2 sites in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to train an AI for video-directed endotracheal intubation (VITION) to recognise the anatomical structures of the upper airway during video-directed endotracheal intubations. Read more about this study

Who is it for?
Any age
What is being tested?
Video-directed endotracheal intubation
How many people
10,000 participants
Where
2 sitesDenmark
Study dates
1 May 2023to 31 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: We will include patients across all ages are eligible for inclusion if they are undergoing video-directed oral or nasal endotracheal intubation in the Capital Region of Denmark.

Who may be able to join

None listed.

Who cannot join

  • Patients are excluded if they adhere to one of the exclusion criteria:
  • Upper airway malformations (e.g., laryngomalacia, vocal cord paralysis, and subglottic stenosis).
  • Failed attempt by video laryngoscopy due to malfunctioning equipment.
  • Missing or corrupted video recording.
  • Informed consent is not obtained from the participants or participants' parents / legal guardians.

Trial locations and contacts

2 sites in 1 country.

Niklas Breindahl, MD contact

+4528566410

niklas.breindahl@gmail.com

Lise Aunsholt, MD, PhD contact

61991137

lise.aunsholt@regionh.dk

Denmark2 sites, 1 recruiting
  • Rigshospitalet

    Copenhagen, 2100

    Active, not recruiting
  • Capital Region of Denmark

    Copenhagen

    Niklas Breindahl, MD, +4528566410, niklas.breindahl@regionh.dk

    Lise Aunsholt, MD, PhD, lise.aunsholt@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: The DAnish VIdeo IntubaTION (DA-VITION) Study: a Prospective Observational Cohort Study

This study aims to train an AI for video-directed endotracheal intubation (VITION) to recognise the anatomical structures of the upper airway during video-directed endotracheal intubations.

Read the detailed description

Study design

The VITION study protocol describes the design of a prospective, observational study. Inclusion will commence in 2023 at the anesthesia and intensive care departments in the Capital Region of Denmark.

Participants

Patients across all ages are eligible for inclusion if they are undergoing video-directed oral or nasal endotracheal intubation.

Exclusion criteria

Patients are excluded if they adhere to one of the exclusion criteria:

  • Upper airway malformations (e.g., laryngomalacia, vocal cord paralysis, and subglottic stenosis17,18).
  • Failed attempt by video laryngoscopy due to malfunctioning equipment.
  • Missing or corrupted video recording.
  • Informed consent is not obtained from the participants or participants' parents / legal guardians.

Interventions and comparisons

This prospective, observational study will have no interventions or comparisons.

Primary objective

The primary objective is to characterize anatomical landmarks and performances of intubations in a large and diverse pool of clinicians and patients.

Being tested
Video-directed endotracheal intubation
Keywords
video-guided endotracheal intubation, artificial intelligence, videolaryngoscope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video-directed endotracheal intubationProcedure or surgery

    There will be no intervention in this prospective observational cohort study. Endotracheal intubation is already used to secure the airway by placing an endotracheal tube into the trachea via the oral or nasal route. Indications include the need for airway control during general anaesthesia, mechanical ventilation, resuscitation, and various forms of acute respiratory distress.

Study groups in NCT05884645
Study groupRoleWhat they receive
Patients undergoing endotracheal intubationPatients across all ages undergoing endotracheal intubation.
Receives: Procedure: Video-directed endotracheal intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Accuracy of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Measured: The landmarks will be identified on the multimedia file from the procedure.

  2. Sensitivity of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Sensitivity of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Measured: The landmarks will be identified on the multimedia file from the procedure.

  3. Specificity of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Specificity of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Measured: The landmarks will be identified on the multimedia file from the procedure.

  4. AUC of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    AUC of the AI algorithm to recognise the anatomical landmarks in the upper airway.

    Measured: The landmarks will be identified on the multimedia file from the procedure.

Secondary outcomes (7)
  1. Time consumption of the course.

    A course is defined as one method for intubation (i.e., the same airway device, approach, and medication regimen). Many attempts by multiple providers are allowed within a given course as long as all attempts are made using the same method.

    Measured: During the procedure.

  2. Number of attempts.

    The number of attempts (one, two, and three or more).

    Measured: During the procedure.

  3. Successful endotracheal intubation.

    Successful endotracheal intubation is defined as correct endotracheal tube placement in the trachea confirmed by chest rise, auscultation, waveform monitor for end-tidal CO2, and/or chest radiograph in first, second, or three attempts.10,19 First-attempt success is defined according to previous studies as successful intubation on the first attempt by the first provider. Success within two attempts is defined as successful intubation on the second attempt by the same provider. Success within 3 attempts is defined as successful intubation on any attempt by the same provider.

    Measured: During the procedure.

  4. Overall course success.

    Overall course success is defined as successful intubation by any provider on any attempt within that course.

    Measured: During the procedure.

  5. Severe oxygen desaturations

    Severe oxygen desaturations are defined according to previous studies as a 20% or more decrease in oxygen saturation from the highest level immediately before the first attempt.

    Measured: During the procedure.

  6. Non-severe TIAEs

    Non-severe TIAEs: Oesophageal intubation with immediate recognition, dysrhythmia including any duration of heart rate <60 beats per minute without chest compressions, main-stem bronchial intubation, emesis without aspiration, pain or agitation requiring additional medications causing a delay in intubation, epistaxis, lip trauma, dental injury, medication error, and hypertension.

    Measured: 72 hours after the procedure

  7. Severe TIAEs

    Severe TIAEs: Cardiac arrest requiring chest compressions, oesophageal intubation with delayed recognition (defined as placement of the endotracheal tube into the oesophagus or hypopharynx with clinical deterioration, e.g., desaturation, before removal of the misplaced tube), emesis with aspiration, hypotension requiring therapy, laryngospasm, pneumothorax or pneumo-mediastinum, and direct airway injury (e.g., vocal cord injury, laryngeal injury, tracheal injury, false passage creation).

    Measured: 72 hours after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2023
  2. Study start1 May 2023
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05884645
Sponsor's protocol ID
The DA-VITION study
Acronym
DA-VITION
Status last verified
Sep 2024
First submitted
23 May 2023
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The Capital Region in Denmark retains all rights to the collected data, which must not be shared without approval.

Questions about this trial

What is this clinical trial studying?

An observational study of Intubation Complication and Intubation; Difficult or Failed, run by Lise Aunsholt at 2 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Niklas Breindahl, MD (+4528566410, niklas.breindahl@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of the AI algorithm to recognise the anatomical landmarks in the upper airway. (time frame: The landmarks will be identified on the multimedia file from the procedure.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in